Close Menu
Newsward
  • World
  • US
    • Politics
  • Tech
    • Science/Tech
  • Money
    • Business and Market Watch
    • Crypto
    • Career
  • Health
    • Fitness
  • State of Women
  • Opinion
  • Sports
    • NFL
    • MLB

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Childhood toxin ‘leading explanation’ for young colon cancer spike

November 19, 2026

Strategy Just Got Dropped From MSCI’s Indexes. Can It Keep Buying Bitcoin?

November 19, 2026

Google gives Gemini the ability to use your Mac for you

November 19, 2026
Newsward
  • World
  • US
    • Politics
  • Tech
    • Science/Tech
  • Money
    • Business and Market Watch
    • Crypto
    • Career
  • Health
    • Fitness
  • State of Women
  • Opinion
  • Sports
    • NFL
    • MLB
Subscribe
Newsward
Home » Common diabetes drug linked to lower risk of death in major health study
Health/Wellness

Common diabetes drug linked to lower risk of death in major health study

Kabil Bendress<span class="bp-verified-badge"></span>By Kabil BendressNovember 13, 2026No Comments3 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
Common diabetes drug linked to lower risk of death in
Share
Facebook Twitter LinkedIn Pinterest Email

Metformin May Enhance COVID-19 Survival for Diabetes Patients

For many years, metformin has been the preferred medication for managing blood sugar levels in individuals with type 2 diabetes. Recent research from Stanford University has indicated that this diabetes medication might have additional benefits, particularly for those who contract COVID-19.

Study Findings

The study, which analyzed the medical records of 53,332 U.S. adults with type 2 diabetes, found that those who were prescribed metformin prior to a COVID-19 diagnosis had a 39% lower risk of dying within a year following their infection compared to those on other diabetes medications known as dipeptidyl peptidase-4 inhibitors (DPP4i).

Understanding the Mechanism

High blood sugar levels can impair immune responses, a consequence highlighted by the Centers for Disease Control and Prevention (CDC). Metformin is known for its ability to lower blood sugar and enhance insulin sensitivity, but researchers are still examining whether these factors directly relate to improved survival rates in COVID-19 patients.

Additionally, scientists suggest that metformin may influence biological pathways related to blood pressure and fluid balance, which could impact COVID-19 severity. Prior studies have also noted its anti-inflammatory properties, which could be beneficial during viral infections.

Research Methodology

In this study, patients examined ranged in age from 30 to 85, all having tested positive for COVID-19 between October 2021 and November 2023. Among them, 50,965 were on metformin, while 2,367 had been prescribed DPP4 inhibitors. The average age of metformin users was 60, compared to 64 for those on DPP4 inhibitors.

Adjustments and Outcomes

After accounting for variables such as age and gender, the data indicated that the metformin group had a significantly improved survival rate in the year following their COVID-19 diagnosis. However, researchers emphasize that this study does not establish a direct causal relationship between metformin usage and increased survival.

Notably, there was an initial indication of a 13% reduction in long COVID symptoms among metformin users, but subsequent analyses showed this correlation was not statistically significant.

Further Research Needed

Other studies have echoed similar findings, such as research from the University of Minnesota Medical School, suggesting metformin taken shortly after a COVID-19 diagnosis could lead to lower mortality and a reduced chance of developing long COVID. Nevertheless, the call for more robust clinical trials remains strong to better understand these potential benefits.

“There is some evidence from the same group that metformin, started early in a COVID infection, may lower the risk of long COVID, but that still needs to be confirmed in large, well-designed randomized trials,” said Dr. Ziyad Al-Aly, a senior clinical epidemiologist.

Considerations for Patients

While the findings are promising, experts caution not to alter current medications based on this study alone. Patients prescribed DPP4 inhibitors often have additional health conditions or age-related factors that necessitate their specific medication choice.

“This is not enough evidence to change treatment,” Dr. Al-Aly added. “If you take either drug, do not change it because of this study.”

As research continues, the hope is to uncover further insights into the relationship between diabetes treatments and COVID-19 outcomes, emphasizing the necessity for thorough scientific investigation before drawing definitive conclusions.

Common Death Diabetes Drug Health Linked Major Risk Study
Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
Previous ArticleTreasury Secretary points to Commerce Secretary on failure to restrict Nvidia customer
Next Article After 3 Weeks and More Than 451,000 Folds, the iPhone Duo’s Hinge Is Finally Starting to Fail
Kabilbendress0
Kabil Bendress

Related Posts

Childhood toxin ‘leading explanation’ for young colon cancer spike

November 19, 2026

The 38 best gifts for health and fitness buffs

November 19, 2026

DOJ charges former Penn State student at center of fraternity drug bust

November 19, 2026

Cincinnati Zoo shares new Fiona video, health update

November 19, 2026

Top Articles

GTA 6 Leak: Cyberleek’s 24-Min Lucia Video [2026]

October 12, 2026

How Novig became the third biggest prediction market site despite launching only months ago

November 14, 2026

How does Iran view shift in US approach after JD Vance ordered away? | US-Israel war on Iran News

November 14, 2026

‘A tremendous step backwards’: US could lose measles elimination status under RFK Jr’s leadership | US news

November 11, 2026

Don't Miss

Health/Wellness

Childhood toxin ‘leading explanation’ for young colon cancer spike

By Kabil BendressNovember 19, 20260

Rising Colorectal Cancer Rates: Uncovering the Early Exposure Link Recent research has highlighted a troubling…

Strategy Just Got Dropped From MSCI’s Indexes. Can It Keep Buying Bitcoin?

November 19, 2026

Google gives Gemini the ability to use your Mac for you

November 19, 2026

US zoo staff monitor Fiona the hippo’s rear end for signs of hat she ate | Ohio

November 19, 2026

Subscribe to Updates

Subscribe to our newsletter and stay updated with the latest news and exclusive offers.

About Us
About Us

NEWSWARD is an independent news and media company covering the economy, politics, international affairs, and a changing world. Through articles, podcasts, video, and candid conversations, we connect major events to their impact on your life, your livelihood, and your future.

Our purpose is simple: help you understand what matters, think critically, and make informed decisions.

See what’s happening now. Know what’s next.

Don't Miss

Childhood toxin ‘leading explanation’ for young colon cancer spike

November 19, 2026

Strategy Just Got Dropped From MSCI’s Indexes. Can It Keep Buying Bitcoin?

November 19, 2026

Google gives Gemini the ability to use your Mac for you

November 19, 2026
Most Viewed

GTA 6 Leak: Cyberleek’s 24-Min Lucia Video [2026]

October 12, 2026

How Novig became the third biggest prediction market site despite launching only months ago

November 14, 2026

How does Iran view shift in US approach after JD Vance ordered away? | US-Israel war on Iran News

November 14, 2026
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Disclaimer
© 2026 Newsward. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.